Brief: Akari Therapeutics Reports Q1 2022 Results

Akari Therapeutics

20/07/2022 11:55

July 20 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PIPELINE PROGRESS
    * AKARI THERAPEUTICS PLC QTRLY LOSS PER ORDINARY SHARE
(BASIC AND
DILUTED) $0.00

Source text for Eikon:  ID:nGNX5ZhBJT 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))